Emek Demir

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Toward better stratification in prostate cancer with AI-assisted multiplex imaging

  Journal of Pathology Informatics · 2026-04-01

• Histopathology Image Normalization via Latent Manifold Compaction

  ArXiv.org · 2026-02-27

• Histopathology Image Normalization via Latent Manifold CompactionPreprint

  Open MIND · 2026-02-27

• Ten Quick Tips for Biomedical Federated LearningPreprint

  Preprints.org · 2026-01-27

• Systems biology graphical notation: process description language level 1 version 2.1

  Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics · 2026-01-22

• Supplementary Table 6 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Fig. 10 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Fig. 3 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Fig. 1 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Table 8 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Table 9 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Table 11 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Table 12 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Table 17 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Table 4 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Fig. 7 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Fig. 4 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Table 18 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Fig. 11 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27

• Supplementary Table 14 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

  2025-11-27